SAGENT PHARMACEUTICALS
SAGENT PHARMACEUTICALS is a federal contractor, registered under UEI PR1HCLM3FMW7 and CAGE code 4RP13. It has been awarded $143,122,820 across 331 federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Medicinal and Botanical Manufacturing, and In-Vitro Diagnostic Substance Manufacturing. Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Department Of Veterans Affairs.
Contact Information
Registration and classification details
Registration
UEI Code
PR1HCLM3FMW7CAGE Code
4RP13Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Sagent Pharmaceuticals, Inc. specializes in the manufacturing of sterile injectable pharmaceuticals for federal healthcare and defense systems, with a primary focus on antimicrobial and anesthetic agents such as levofloxacin and propofol. The company demonstrates deep technical expertise in aseptic ...
Sagent Pharmaceuticals, Inc. specializes in the manufacturing of sterile injectable pharmaceuticals for federal healthcare and defense systems, with a primary focus on antimicrobial and anesthetic agents such as levofloxacin and propofol. The company demonstrates deep technical expertise in aseptic processing, lyophilization, and parenteral formulation development, ensuring compliance with cGMP standards for mission-critical medical supplies. Their ability to consistently deliver high-volume, sterile IV solutions in standardized packaging formats—such as 100mL vials and dextrose-based infusions—reflects advanced capabilities in sterile manufacturing, batch traceability, and cold chain logistics tailored to military and veteran healthcare requirements. The contractor maintains a strong, recurring relationship with the Department of Defense, supplying essential medications used in field hospitals, combat support units, and military medical facilities. Additional work with the Department of Veterans Affairs and the Department of Health and Human Services underscores their role in sustaining the federal pharmaceutical supply chain for chronic care and emergency readiness. Their contracts consistently involve high-priority therapeutics requiring strict regulatory adherence and rapid turnaround, indicating a proven capacity to meet urgent operational needs. Sagent’s primary industry focus is medicinal and botanical manufacturing (NAICS 325411), where they produce active pharmaceutical ingredients and finished dosage forms for injectable use. This vertical specialization positions them as a reliable vendor for government agencies requiring sterile, single-dose, and multi-dose parenteral products with validated stability profiles. While they also engage in pharmaceutical preparation manufacturing (NAICS 325412), their operational emphasis remains on complex injectable formulations critical to tactical and clinical care settings. As a 2L entity based in Schaumburg, Illinois, Sagent Pharmaceuticals operates as a mid-sized manufacturer without federal certifications such as 8(a), HUBZone, or WOSB. Their geographic footprint is centered in the Midwest, with a government market presence defined by consistent, mission-driven supply contracts rather than broad commercial outreach.
Key Performance Metrics
Awards Count
All time
Active
Currently performing
Completed
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with SAGENT PHARMACEUTICALS
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for SAGENT PHARMACEUTICALS
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 650+ contractors already using CLEATUS
